Want to see JP:9245 full AI Analyst Report?
Top Page
Livero Inc.
(9245)
Select Model
Select Model
Rating:69Neutral
Price Target:
¥2,153.00
▼(-4.44% Downside)
Action:Reiterated
Date:02/18/26
The score is primarily supported by strong financial fundamentals—debt-free balance sheet, rising equity, and improving profitability with accelerating revenue growth. This is tempered by weak near-term technicals (below key moving averages with negative MACD) and a valuation that looks reasonable but not clearly cheap (P/E ~22.5, modest ~1.36% yield).
Positive Factors
Debt-free balance sheet
Zero reported debt and steadily rising equity (from ~¥0.93B in 2020 to ~¥2.66B in 2025) give durable financial flexibility. This reduces refinancing risk, supports investment or opportunistic M&A, and preserves stability through business cycles over the next several quarters.
Negative Factors
Margin variability
Gross margin has trended down from earlier peaks and profitability showed notable swings, reducing predictability of operating and net margins. Persistent margin pressure could limit sustainable profitability and weaken the company's ability to generate stable returns over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
Zero reported debt and steadily rising equity (from ~¥0.93B in 2020 to ~¥2.66B in 2025) give durable financial flexibility. This reduces refinancing risk, supports investment or opportunistic M&A, and preserves stability through business cycles over the next several quarters.
Read all positive factors
Livero Inc. (9245) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥10.70B
Dividend Yield1.35%
Average Volume (3M)4.73K
Price to Earnings (P/E)14.2
Beta (1Y)0.37
Revenue Growth25.25%
EPS Growth124.85%
CountryJP
Employees147
SectorGeneral
Sector StrengthN/A
IndustryInternet Content & Information
Share Statistics
EPS (TTM)135.70
Shares Outstanding5,440,400
10 Day Avg. Volume8,640
30 Day Avg. Volume4,733
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)4.40
Price to Sales (P/S)2.68
P/FCF Ratio12.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)150.8
Revenue Forecast (FY)¥5.40B
Livero Inc. Business Overview & Revenue Model
Company Description
Based in Japan, Livero Inc. operates a cloud-based platform that assists individuals in establishing new living situations. This service streamlines the entire relocation process, from identifying rental properties and coordinating moves to arrang...
Livero Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.66B | 4.36B | 3.59B | 2.90B | 2.56B | 2.38B |
| Gross Profit | 3.31B | 3.14B | 2.85B | 2.46B | 2.23B | 2.05B |
| EBITDA | 1.10B | 838.91M | 513.81M | 217.08M | 111.80M | 386.12M |
| Net Income | 717.63M | 531.62M | 338.92M | 103.94M | 50.78M | 239.01M |
Balance Sheet | ||||||
| Total Assets | 9.75B | 7.49B | 5.83B | 4.40B | 3.46B | 3.05B |
| Cash, Cash Equivalents and Short-Term Investments | 1.45B | 2.32B | 1.91B | 1.53B | 1.45B | 1.75B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.88B | 4.83B | 3.58B | 2.50B | 1.57B | 1.22B |
| Stockholders Equity | 2.87B | 2.66B | 2.25B | 1.89B | 1.89B | 1.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 952.74M | 806.67M | 483.33M | 6.97M | 273.24M |
| Operating Cash Flow | 0.00 | 963.79M | 828.46M | 496.81M | 10.57M | 330.92M |
| Investing Cash Flow | 0.00 | -480.15M | -456.60M | -320.96M | -316.95M | -126.22M |
| Financing Cash Flow | 0.00 | -117.08M | 16.87M | -102.74M | 6.41M | 666.90M |
Livero Inc. Technical Analysis
Positive
2253.00
Price Trends
1935.78
Positive
2047.07
Negative
2224.47
Negative
Market Momentum
1.93
Negative
55.14
Neutral
67.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9245, the sentiment is Positive. The current price of 2253 is above the 20-day moving average (MA) of 1918.30, above the 50-day MA of 1935.78, and above the 200-day MA of 2224.47, indicating a neutral trend. The MACD of 1.93 indicates Negative momentum. The RSI at 55.14 is Neutral, neither overbought nor oversold. The STOCH value of 67.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9245.
Livero Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥33.19B | 12.29 | ― | 0.38% | 16.53% | 76.82% | |
74 Outperform | ¥6.36B | 12.15 | ― | 3.29% | 2.36% | -15.08% | |
69 Neutral | ¥10.70B | 14.22 | ― | 1.35% | 25.25% | 124.85% | |
58 Neutral | ¥12.18B | 10.76 | ― | ― | 18.15% | -47.04% | |
57 Neutral | ¥12.03B | 26.90 | ― | 1.09% | -1.25% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
JP:9245
Livero Inc.
1,926.00
238.89
14.16%
JP:2489
Adways, Inc.
312.00
-18.22
-5.52%
JP:3675
Cross Marketing Group, Inc.
597.00
-94.45
-13.66%
JP:3922
PR TIMES Corporation
2,212.00
-722.92
-24.63%
JP:6180
GMO Media, Inc.
3,735.00
-933.28
-19.99%
JP:6562
Geniee, Inc.
1,023.00
-489.00
-32.34%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.